Inhibition of bacterial cell wall-induced leukocyte recruitment and hepatic granuloma formation by TGF-beta gene transfer.
Intraperitoneal injection of streptococcal cell walls (SCW) into Lewis rats results in dissemination of SCW to the liver, spleen, bone marrow, and peripheral joints. The uptake of SCW by Kupffer cells in the liver initiates a chain of events largely mediated by T lymphocytes and macrophages. Local synthesis and secretion of cytokines and growth factors in response to the persistent SCW lead to the evolution and maintenance of a chronic T cell-dependent granulomatous response and result in granuloma formation and irreversible hepatic fibrosis. In an attempt to impede the development of the chronic granulomatous lesions in the liver, we injected a plasmid DNA encoding TGF-beta 1 i.m. to the SCW animals to determine the effect of TGF-beta 1 gene transfer on the course of liver inflammation and fibrosis. A single injection of plasmid DNA encoding TGF-beta 1 resulted in virtual abolition of the development of the SCW-induced hepatic granuloma formation and matrix expansion. TGF-beta 1 DNA not only reduced key proinflammatory cytokines including TNF-alpha, IL-1 beta, IFN-gamma, and IL-18, but also inhibited both CXC and CC chemokine production, thereby blocking inflammatory cell recruitment and accumulation in the liver. Moreover, TGF-beta 1 gene delivery inhibited its own expression in the liver tissue, which is otherwise up-regulated in SCW-injected animals. Our study suggests that TGF-beta 1 gene transfer suppresses hepatic granuloma formation by blocking the recruitment of inflammatory cells to the liver, and thus may provide a new approach to the control of hepatic granulomatous and fibrotic diseases.
Song
X
X
Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD 20892, USA.
Zeng
L
L
Pilo
C M
CM
Zagorski
J
J
Wahl
S M
SM
D000818:Animals; D002465:Cell Movement / Q000235:genetics / Q000276:immunology*; D002473:Cell Wall / Q000276:immunology*; D016207:Cytokines / Q000235:genetics; D004247:DNA / Q000008:administration & dosage; D016326:Extracellular Matrix Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005260:Female; D018014:Gene Transfer Techniques; D006099:Granuloma / Q000235:genetics* / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007962:Leukocytes / Q000276:immunology* / Q000473:pathology; D008107:Liver Diseases / Q000235:genetics* / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D013297:Streptococcus pyogenes / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000008:administration & dosage / Q000235:genetics*
D016207:Cytokines; D016326:Extracellular Matrix Proteins; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D004247:DNA